The 4th TGF for Immuno-Oncology Drug Development Summit is dedicated to taming the TGFβ double-edged sword for tumor suppression.
The 4th TGF for Immuno-Oncology Drug Development Summit covers topics such as:
- Targeting TGF-ß through Integrin Inhibition: Small Molecule vs Antibody Approaches
- TGF-ß in Immuno-oncology Drug Development: Current State of Play
- Targeting with Anti-TGF-ß Traps
- Exploring Mechanism of Action and Biomarker Development
- Dissecting the Dual Relationships between CAR-T & TGF-ß
- Advancing Antibody Approaches
- Translating TGFß into the Clinic
- ATAC Platform & Antisense Agents
